Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Maryland, Baltimore
Massachusetts General Hospital
Stanford University
University of California, San Francisco
Northwestern University
National Institutes of Health Clinical Center (CC)